Hepatic Impairment: Hepatic metabolism accounts for almost 100% of diclofenac sodium prolonged-release tablets elimination, so patients with hepatic condition could have to have lessened doses of diclofenac sodium prolonged-launch tablets when compared to patients with normal hepatic function. The performance and basic safety of diclofenac therapy depend on its appropriate https://francisv799soh4.bloggerswise.com/profile